Skip to main content
Clinical Trials/NCT04160442
NCT04160442
Completed
N/A

Use of a Patient Preferences Shared Decision-Making Encounter Tool in Clinical Practice for Patients With DLBCL and FL

Carevive Systems, Inc.1 site in 1 country46 target enrollmentJanuary 16, 2009

Overview

Phase
N/A
Intervention
Not specified
Conditions
Diffuse Large B Cell Lymphoma
Sponsor
Carevive Systems, Inc.
Enrollment
46
Locations
1
Primary Endpoint
Satisfaction of using the Carevive treatment planning system in shared decision making will be collected from both patient and provider perspectives: questionnaires
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The goal of this project is to test the feasibility of a Patient Preferences in Shared Decision-Making encounter tool (PPSDM) in the clinical context of Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL). This project will evaluate the feasibility of a shared decision-making (SDM) model that employs an "encounter tool"1 to facilitate SDM at the point of a treatment decision for patients with DLBCL and FL.

Detailed Description

This project is a single-arm pilot project conducted with 90 patients with newly diagnosed or recurrent DLBCL or FL and their providers at three medical oncology practices. Utilizing the PPSDM tool in the Carevive electronic platform, patients will report their needs, preferences, values and goal prior to the treatment decision-making focused clinical encounter. The treating provider will receive the patient results prior to the visit and can use these to facilitate SDM in treatment selection during the clinical encounter. Post-encounter, patients and providers will complete measures designed to assess feasibility and utility of SDM intervention. Patients will also complete measures to assess patient satisfaction with the treatment decision, patient activation, and patient perceived achievement of desired role in shared decision making and satisfaction with care.

Registry
clinicaltrials.gov
Start Date
January 16, 2009
End Date
June 30, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All participants must be 18 years of age or older.
  • Patient participants must have a diagnosis of new or recurrent DLBCL or FL
  • All participants must be able to understand English.

Exclusion Criteria

  • Any patient who cannot understand written or spoken English.
  • Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).

Outcomes

Primary Outcomes

Satisfaction of using the Carevive treatment planning system in shared decision making will be collected from both patient and provider perspectives: questionnaires

Time Frame: 3 months

patient and providers will complete questionnaires at each clinic visit. These questions will determine their satisfaction with the treatment care planning system.

Secondary Outcomes

  • Evaluation of patient satisfaction and perceived shared decision making utilizing surveys at each clinic visit(3 months)

Study Sites (1)

Loading locations...

Similar Trials